Table 4:
Estimated location of HIV acquisition, African-born people with a new HIV diagnosis, 2000–2017, King County, WA, New York City, Chicago, and Philadelphia*
| Definitely Africa | Probably Africa | Probably U.S. | Definitely U.S. | Inadequate information | Total | |
|---|---|---|---|---|---|---|
|
| ||||||
| All participants (N, %) | 92 (51.4) | 9 (5.0) | 12 (6.7) | 29 (16.2) | 37 (20.7) | 179 (100) |
| Percent in each category excluding those with inadequate information | 64.8 | 6.3 | 8.5 | 20.4 | -- | |
| Diagnosed in the U.S. (%) | 25 (28.1) | 9 (100) | 12(100) | 28 (100) | 36 (100) | 110 (63.2) |
| Median time in U.S. to diagnosis^ (years, range) | 0.5 (0.1 –7.6) | 1.4 (0.50–10.0) | 6.6 (0.75–15.1) | 5.0 (0.50–30.6) | 3.2 (0.17–22.3) | 2.6 (0.7–30.6) |
| Median CD4 at diagnosis* (range) | 135 (13–1053) | 89 (26–303) | 274 (0–627) | 394 (20–656) | 321 (4–818) | 293 (0–1053) |
| Concurrent HIV and AIDS diagnosi^ (%) | 12 (54.6) | 8 (100) | 5 (45.5) | 6 (25.0) | 11 (40.7) | 42 (45.6) |
| Had ≥1 negative HIV test in the U.S.^ (%) | 0 (0) | 0 (0) | 2 (20.0) | 13 (44.8) | 2 (5.7) | 0 (0.0) |
While participants were newly diagnosed in the U.S. from 2000–2017, in some cases they reported positive tests outside of the U.S. prior to 2000.
Among those diagnosed in the U.S.